Nanostics Inc.

Nanostics Inc.

Private
EdmontonHealthcare & Life Scienceshttps://nanosticsdx.com

Last Round

Grant

Jun 26, 2025

Total Funding Raised

$1.71M

Momentum Score

25 /100

Company Overview

Nanostics Inc. is a diagnostic equipment company that develops and commercializes non-invasive diagnostic tests using its ClarityDX® platform, which employs machine learning to generate risk scores for various diseases like cancer.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Biotechnology

Business Model

B2B

Customer Profile

Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

prostate cancer diagnosticsliquid biopsyAI diagnosticsClarityDX Prostatebiopsy avoidancecancer risk scorelaboratory developed testLDTnon-invasive diagnosticsprecision medicineprostate cancer blood testbiomarker testPSA test alternativeclinical laboratorypatient-pay service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanostics Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nanostics Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJun 26, 2025
VC RoundApr 23, 2024
GrantMay 28, 2018

Key People

Founding team and executive leadership

Catalina Vasquez

Co-Founder COO

Founding Team

John Lewis

Founder, CEO

Founding Team

Nanostics Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 28, 2025

    Expanding offices to Middle, New Jersey for US market entry.

  • Jun 1, 2025

    Expanded product availability to four Canadian provinces in summer 2025.

Nanostics Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanostics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanostics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersEdmonton
Employee Range18
Year Founded2017
Last FundingJun 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.